Description
The Defense Logistics Agency (DLA) is issuing a solicitation for the procurement of Azithromycin tablets in several dosage and packaging configurations. The contract will cover a Base Year plus up to four option years, with estimated quantities for each product listed in the Schedule of Supplies. The items include 250 mg tablets in 6‑count and 30‑count bottles, and 500 mg tablets in 3‑count and 30‑count bottles. Quantities are provided per year and are estimates only. The solicitation references FAR 52.216‑21 for order‑quantity pricing, indicating that pricing will be based on the volume ordered. Potential contractors must be able to supply the pharmaceutical product in compliance with the National Drug Code (NDC) requirements and the “Preparation for Delivery” statement of work.
• Supplies: Azithromycin 250 mg (6‑count & 30‑count) and 500 mg (3‑count & 30‑count) tablets.
• Estimated annual quantities: ~139,001 (6‑count), ~124,934 (30‑count 250 mg), ~7,140 (3‑count 500 mg), ~26,205 (30‑count 500 mg).
• Contract term: Base Year plus up to four option years (total up to 5 years).
• Pricing: Order‑quantity pricing per FAR 52.216‑21; unit prices not disclosed in the excerpt.
• Delivery: Must meet DLA packaging and labeling requirements (NDC, bottle or blister packaging).
• Evaluation: Likely based on price, compliance with specifications, and ability to meet delivery schedules.